Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Profound Medical (PROF) Gains from Sales and Divestitures (2023 - 2026)

Profound Medical has reported Gains from Sales and Divestitures over the past 3 years, most recently at $16665.0 for Q4 2025.

  • For Q4 2025, Gains from Sales and Divestitures fell 92.72% year-over-year to $16665.0; the TTM value through Dec 2025 reached $16665.0, down 92.72%, while the annual FY2025 figure was $16665.0, 92.72% down from the prior year.
  • Gains from Sales and Divestitures for Q4 2025 was $16665.0 at Profound Medical, down from $145448.0 in the prior quarter.
  • Over five years, Gains from Sales and Divestitures peaked at $228774.0 in Q4 2024 and troughed at $10000.0 in Q4 2023.
  • A 3-year average of $71258.8 and a median of $14999.0 in 2025 define the central range for Gains from Sales and Divestitures.
  • Biggest five-year swings in Gains from Sales and Divestitures: skyrocketed 2187.74% in 2024 and later crashed 92.72% in 2025.
  • Year by year, Gains from Sales and Divestitures stood at $10000.0 in 2023, then skyrocketed by 2187.74% to $228774.0 in 2024, then crashed by 92.72% to $16665.0 in 2025.
  • Business Quant data shows Gains from Sales and Divestitures for PROF at $16665.0 in Q4 2025, $145448.0 in Q3 2025, and $13333.0 in Q2 2025.